A PYMNTS Company

UK Watchdog Provisionally Clears $1.58B UnitedHealth-EMIS Deal

By  |  August 13, 2023

The UnitedHealth Group’s proposed acquisition of EMIS, a healthcare technology firm, was approved by the Competition and Markets Authority in the UK. Aby Jose Koilparambil, a Reuters reporter, said. “Britain’s competition regulator has provisionally cleared UnitedHealth Group’s acquisition of healthcare technology firm EMIS.” Eva Mathews, also with Reuters, adds “The Competition and Markets Authority found no competition concerns in the deal between specialist health care tech and software companies.”

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    The offer to acquire EMIS was made by Optum UK, a subsidiary of UnitedHealth, in June last year. The CMA launched its initial merger enquiry in January and referred the deal to a deeper probe in March. However, after a thorough investigation, the CMA found that no competition concerns are present in the deal, allowing for the acquisition to be approved.

    Related: UK Watchdog Says UnitedHealth Takeover Of EMIS Could Hurt National Health Service

    Together, Optum UK and EMIS will work to create a more innovative healthcare sector. UnitedHealth Group commented on the deal as a “strong bridge between the skills, innovations and networks of both companies”. With the approval of the CMA, both companies are now able to pursue their mission to bring high quality healthcare to people across the UK.

    Source: Saltwire